- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/763 - Herpes virus
Patent holdings for IPC class A61K 35/763
Total number of patents in this class: 416
10-year publication summary
|
15
|
28
|
38
|
49
|
72
|
42
|
62
|
33
|
36
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3145 |
21 |
| Virogin Biotech Canada Ltd. | 47 |
19 |
| Amgen Inc. | 4072 |
18 |
| Replimune Limited | 42 |
16 |
| Krystal Biotech, Inc. | 64 |
15 |
| Alma Mater Studiorum - Universita di Bologna | 404 |
13 |
| The Brigham and Women's Hospital, Inc. | 2185 |
11 |
| Research Institute at Nationwide Children's Hospital | 559 |
8 |
| University of Houston System | 1083 |
8 |
| Virttu Biologics Limited | 18 |
8 |
| Hangzhou Converd Co., Ltd. | 34 |
7 |
| The Regents of the University of California | 19898 |
6 |
| City of Hope | 988 |
6 |
| Ohio State Innovation Foundation | 2131 |
6 |
| Oncorus, Inc. | 22 |
6 |
| Gencellmed Inc. | 11 |
6 |
| Benevir Biopharm, Inc. | 8 |
5 |
| New York University | 1745 |
5 |
| The University of Tokyo | 4173 |
5 |
| Xiamen University | 536 |
5 |
| Other owners | 222 |